dermatan sulfate has been researched along with Necrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J | 1 |
| Hulett, MD; Parish, CR; Poon, IK | 1 |
| Carnelli, V; Gatti, L; Moia, M; Rusconi, R | 1 |
| Bartholomew, JR | 1 |
| Bredlich, RO; Gall, H; Proebstle, TM; Stracke, S | 1 |
| Ansell, J; Cola, C | 1 |
2 review(s) available for dermatan sulfate and Necrosis
| Article | Year |
|---|---|
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis | 1990 |
4 other study(ies) available for dermatan sulfate and Necrosis
| Article | Year |
|---|---|
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2017 |
Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake.
Topics: Animals; Cell Communication; Cell Line; Cell Membrane; Cell Survival; Chondroitin Sulfates; Dermatan Sulfate; Hemin; Heparin; Heparitin Sulfate; Humans; Models, Immunological; Necrosis; Phagocytes; Phagocytosis; Protein Binding; Proteins; T-Lymphocytes; Zinc | 2010 |
Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate.
Topics: Anticoagulants; Child; Dermatan Sulfate; Heparin; Humans; Male; Necrosis; Protein C; Protein C Deficiency; Skin; Thrombocytopenia; Warfarin | 2003 |
[Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Foot Dermatoses; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Necrosis; Platelet Aggregation; Renal Dialysis; Skin; Skin Diseases | 1997 |